SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-16-141546
Filing Date
2016-09-15
Accepted
2016-09-15 14:54:33
Documents
2
Period of Report
2016-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4554
2 POA DOCUMENT poa.txt EX-24.4A_675523 3102
  Complete submission text file 0001209191-16-141546.txt   9111
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 350 CAMBRIDGE AVE, SUITE 350 PALO ALTO CA 94306
Business Address
Martins Eduardo Bruno (Reporting) CIK: 0001670431 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36183 | Film No.: 161887021